{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T02:35:32Z","timestamp":1764729332513,"version":"3.46.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2024J011363"],"award-info":[{"award-number":["2024J011363"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Innovation Project of the Xiamen Health and Wellness High-Quality Development Science and Technology Program","award":["2024GZL-CX16","2024GZL-CX16"],"award-info":[{"award-number":["2024GZL-CX16","2024GZL-CX16"]}]},{"DOI":"10.13039\/501100018540","name":"Science Fund for Distinguished Young Scholars of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010086"],"award-info":[{"award-number":["2023A1515010086"]}],"id":[{"id":"10.13039\/501100018540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06520-w","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T05:01:00Z","timestamp":1755752460000},"page":"5773-5782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Initial local treatment strategies on survival outcomes of early-stage breast mucosa-associated lymphoid tissue lymphoma"],"prefix":"10.1007","volume":"104","author":[{"given":"Hong-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"San-Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"6","key":"6520_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/ajcp\/aqaa005","volume":"153","author":"A Travaglino","year":"2020","unstructured":"Travaglino A, Giordano C, Pace M, Varricchio S, Picardi M, Pane F et al (2020) Sj\u00f6gren syndrome in primary salivary gland lymphoma. Am J Clin Pathol 153(6):719\u2013724","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"6520_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","volume":"31","author":"E Zucca","year":"2020","unstructured":"Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M et al (2020) Marginal zone lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(1):17\u201329","journal-title":"Ann Oncol"},{"issue":"2","key":"6520_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11864-025-01293-w","volume":"26","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Yan W, Li H, Peng H (2025) Advances in the pathogenesis, diagnosis, treatment, and prognosis of marginal zone lymphoma. Curr Treat Options Oncol 26(2):142\u2013155","journal-title":"Curr Treat Options Oncol"},{"issue":"2","key":"6520_CR4","first-page":"153","volume":"66","author":"M Raderer","year":"2016","unstructured":"Raderer M, Kiesewetter B, Ferreri AJ (2016) Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). CA Cancer J Clin 66(2):153\u2013171","journal-title":"CA Cancer J Clin"},{"key":"6520_CR5","doi-asserted-by":"publisher","first-page":"105683","DOI":"10.1016\/j.humpath.2024.105683","volume":"156","author":"R Segura-Rivera","year":"2025","unstructured":"Segura-Rivera R, Pina-Oviedo S (2025) Marginal zone lymphoma of extranodal sites: a review with an emphasis on diagnostic pitfalls and differential diagnosis with reactive conditions. Hum Pathol 156:105683","journal-title":"Hum Pathol"},{"key":"6520_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40364-016-0068-1","volume":"4","author":"Q Hu","year":"2016","unstructured":"Hu Q, Zhang Y, Zhang X, Fu K (2016) Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and management. Biomark Res 4:15","journal-title":"Biomark Res"},{"issue":"2","key":"6520_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3816\/CBC.2008.n.020","volume":"8","author":"RR Rajendran","year":"2008","unstructured":"Rajendran RR, Palazzo JP, Schwartz GF, Glick JH, Solin LJ (2008) Primary mucosa-associated lymphoid tissue lymphoma of the breast. Clin Breast Cancer 8(2):187\u2013188","journal-title":"Clin Breast Cancer"},{"key":"6520_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijscr.2016.05.041","volume":"25","author":"SB Koganti","year":"2016","unstructured":"Koganti SB, Lozada A, Curras E, Shah A (2016) Marginal zone lymphoma of the breast-a diminished role for surgery. Int J Surg Case Rep 25:4\u20136","journal-title":"Int J Surg Case Rep"},{"issue":"3","key":"6520_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/10428194.2021.1992764","volume":"63","author":"SG Iyer","year":"2022","unstructured":"Iyer SG, Kuker R, Florindez JA, Saul E, Trabolsi A, Rodriguez G et al (2022) A single-center analysis of patients with extranodal marginal zone lymphoma of the breast. Leuk Lymphoma 63(3):591\u2013598","journal-title":"Leuk Lymphoma"},{"key":"6520_CR10","first-page":"1831792","volume":"2016","author":"M Hissourou Iii","year":"2016","unstructured":"Hissourou Iii M, Zia SY, Alqatari M, Strauchen J, Bakst RL (2016) Primary MALT lymphoma of the breast treated with definitive radiation. Case Rep Hematol 2016:1831792","journal-title":"Case Rep Hematol"},{"issue":"16","key":"6520_CR11","doi-asserted-by":"publisher","first-page":"e37895","DOI":"10.1097\/MD.0000000000037895","volume":"103","author":"S Luo","year":"2024","unstructured":"Luo S, Zhang X, Wang Z (2024) Breast mucosa-associated lymphoid tissue lymphoma: a case report and literature review. Medicine 103(16):e37895","journal-title":"Medicine"},{"issue":"4","key":"6520_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.clml.2018.12.016","volume":"19","author":"EB Ludmir","year":"2019","unstructured":"Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Fayad LE et al (2019) Emerging treatment strategies for primary breast extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. Clin Lymphoma Myeloma Leuk 19(4):244\u2013250","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"6520_CR13","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1093\/annonc\/mdp238","volume":"20","author":"G Martinelli","year":"2009","unstructured":"Martinelli G, Ryan G, Seymour JF, Nassi L, Steffanoni S, Alietti A et al (2009) Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the international extranodal lymphoma study group. Ann Oncol 20(12):1993\u201319999","journal-title":"Ann Oncol"},{"key":"6520_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jpra.2022.01.004","volume":"32","author":"ER James","year":"2022","unstructured":"James ER, Miranda RN, Turner SD (2022) Primary lymphomas of the breast: a review. JPRAS Open 32:127\u2013143","journal-title":"JPRAS Open"},{"issue":"2","key":"6520_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10549-024-07258-1","volume":"205","author":"Y Shibahara","year":"2024","unstructured":"Shibahara Y, Delabie JMA, Kulkarni S, Grant A, Prica A, McCready DR et al (2024) Primary MALT lymphoma of the breast: pathological and radiological characteristics. Breast Cancer Res Treat 205(2):387\u2013394","journal-title":"Breast Cancer Res Treat"},{"key":"6520_CR16","unstructured":"National Comprehensive Cancer Network (NCCN) clinical practice guidelines in Oncology. B-Cell Lymphomas 2025. Version 2. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b-cell.pdf. Accessed 6 Mar 2025"},{"key":"6520_CR17","unstructured":"Surveillance E, Results E (2022) (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Data, 17 Registries, Nov 2022 Sub (2000\u20132020) - Linked To County Attributes - Time Dependent (1990\u20132021) Income\/Rurality, 1969\u20132021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November submission"},{"issue":"15","key":"6520_CR18","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.3390\/cancers15153811","volume":"15","author":"T Matysiak-Budnik","year":"2023","unstructured":"Matysiak-Budnik T, Priadko K, Bossard C, Chapelle N, Ruskon\u00e9-Fourmestraux A (2023) Clinical management of patients with gastric MALT lymphoma: a gastroenterologist\u2019s point of view. Cancers (Basel) 15(15):3811","journal-title":"Cancers (Basel)"},{"issue":"4","key":"6520_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","volume":"61","author":"S Nakamura","year":"2012","unstructured":"Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M et al (2012) Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut 61(4):507\u2013513","journal-title":"Gut"},{"key":"6520_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.radonc.2022.05.034","volume":"173","author":"Y Wu","year":"2022","unstructured":"Wu Y, Liu X, Imber BS, Zhong QZ, Yang Y, Wu T et al (2022) Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: a SEER database analysis (2000\u20132015). Radiother Oncol 173:179\u2013187","journal-title":"Radiother Oncol"},{"issue":"1","key":"6520_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/jcp.56.1.74","volume":"56","author":"M Kambouchner","year":"2003","unstructured":"Kambouchner M, Godmer P, Guillevin L, Rapha\u00ebl M, Droz D, Martin A (2003) Low grade marginal zone B cell lymphoma of the breast associated with localised amyloidosis and corpora amylacea in a woman with long standing primary Sj\u00f6gren\u2019s syndrome. J Clin Pathol 56(1):74\u201377","journal-title":"J Clin Pathol"},{"issue":"7","key":"6520_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00277-003-0664-7","volume":"82","author":"MJ Kuper-Hommel","year":"2003","unstructured":"Kuper-Hommel MJ, Snijder S, Janssen-Heijnen ML, Vrints LW, Kluin-Nelemans JC, Coebergh JW et al (2003) Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews. Ann Hematol 82(7):397\u2013404","journal-title":"Ann Hematol"},{"issue":"33","key":"6520_CR23","doi-asserted-by":"publisher","first-page":"8442","DOI":"10.1200\/JCO.2004.00.8532","volume":"23","author":"M Raderer","year":"2005","unstructured":"Raderer M, W\u00f6hrer S, Bartsch R, Prager G, Drach J, Hejna M et al (2005) Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 23(33):8442\u20138446","journal-title":"J Clin Oncol"},{"issue":"3","key":"6520_CR24","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2325\/jbcs.13.322","volume":"13","author":"Y Taeda","year":"2006","unstructured":"Taeda Y, Ariga N, Okamura K, Takei N, Komeno T, Ueki H et al (2006) Primary breast mucosa-associated lymphoid tissue (MALT) lymphoma with high-grade transformation evidenced by prominent lymphoepithelial lesions. Breast Cancer 13(3):322\u2013327","journal-title":"Breast Cancer"},{"issue":"6","key":"6520_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/01.coc.0000248930.12423.2e","volume":"29","author":"JS Welsh","year":"2006","unstructured":"Welsh JS, Howard A, Hong HY, Lucas D, Ho T, Reding DJ (2006) Synchronous bilateral breast mucosa-associated lymphoid tissue lymphomas addressed with primary radiation therapy. Am J Clin Oncol 29(6):634\u2013635","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"6520_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3816\/CBC.2008.n.033","volume":"8","author":"NS Anavekar","year":"2008","unstructured":"Anavekar NS, Rozen WM, Rowe K, Murphy C (2008) Synchronous carcinoma and lymphoma of the breast. Clin Breast Cancer 8(3):281\u2013284","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"6520_CR27","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.4081\/rt.2009.e14","volume":"1","author":"O Julen","year":"2009","unstructured":"Julen O, Dellacasa I, Pelte MF, Borish B, Bouchardy C, Capanna F et al (2009) Primary breast lymphomas. Rare Tumors 1(1):e14","journal-title":"Rare Tumors"},{"issue":"5","key":"6520_CR28","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00404-011-2015-6","volume":"284","author":"D Ghetu","year":"2011","unstructured":"Ghetu D, Membrez V, Bregy A, Vees HG, Hottelier D, Girardet C et al (2011) Expect the unexpected: primary breast MALT lymphoma. Arch Gynecol Obstet 284(5):1323\u20131324","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"6520_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.5505\/tjh.2012.26214","volume":"29","author":"SH Arslan","year":"2012","unstructured":"Arslan SH, Uyet\u00fcrk U, Tekg\u00fcnd\u00fcz E, Irkkan S\u00c7, Kurt MY, Demiriz I\u015e et al (2012) Primary breast Mucosa-Associated lymphoid tissue (MALT) lymphoma transformation to diffuse large B-cell lymphoma: A case report. Turk J Haematol 29(3):274\u2013277","journal-title":"Turk J Haematol"},{"issue":"6","key":"6520_CR30","doi-asserted-by":"publisher","first-page":"E141","DOI":"10.1111\/petr.12111","volume":"17","author":"S Nassif","year":"2013","unstructured":"Nassif S, Ozdemirli M (2013) EBV-positive low-grade marginal zone lymphoma in the breast with massive amyloid deposition arising in a heart transplant patient: a report of an unusual case. Pediatr Transplant 17(6):E141\u2013145","journal-title":"Pediatr Transplant"},{"issue":"2","key":"6520_CR31","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1097\/RLU.0000000000000545","volume":"40","author":"DH Kim","year":"2015","unstructured":"Kim DH, Jeong JY, Lee SW, Lee J, Ahn BC (2015) 18F-FDG PET\/CT finding of bilateral primary breast mucosa-associated lymphoid tissue lymphoma. Clin Nucl Med 40(2):e148\u2013149","journal-title":"Clin Nucl Med"},{"issue":"10","key":"6520_CR32","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.radcr.2022.07.105","volume":"17","author":"CDM Anendaga","year":"2022","unstructured":"Anendaga CDM, Raghu M, Szarmach JL, Bakhru S, Flaherty FT, Boroumand G (2022) A rare case of synchronous mucosa-associated lymphoid tissue (MALT) lymphoma involving bilateral breasts and subcutaneous tissues. Radiol Case Rep 17(10):4049\u20134052","journal-title":"Radiol Case Rep"},{"issue":"1","key":"6520_CR33","first-page":"e34286","volume":"15","author":"H Dalal","year":"2023","unstructured":"Dalal H, Yu A, Antoine-Pepeljugoski C (2023) A rare case of breast mucosa-associated lymphoid tissue (MALT) lymphoma with amyloid deposition in a patient with Sjogren\u2019s syndrome. Cureus 15(1):e34286","journal-title":"Cureus"},{"issue":"4","key":"6520_CR34","doi-asserted-by":"publisher","first-page":"e70435","DOI":"10.1002\/ccr3.70435","volume":"13","author":"J Hui","year":"2025","unstructured":"Hui J, Bashir A, Policeni F, Kim Hsieh S (2025) Primary breast extranodal marginal zone lymphoma: A case report and brief review of the literature. Clin Case Rep 13(4):e70435","journal-title":"Clin Case Rep"},{"issue":"20","key":"6520_CR35","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1182\/bloodadvances.2021004939","volume":"5","author":"BS Imber","year":"2021","unstructured":"Imber BS, Chau KW, Lee J, Lee J, Casey DL, Yang JC et al (2021) Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients? Blood Adv 5(20):4185\u20134197","journal-title":"Blood Adv"},{"key":"6520_CR36","doi-asserted-by":"publisher","first-page":"110591","DOI":"10.1016\/j.radonc.2024.110591","volume":"202","author":"F De Rose","year":"2025","unstructured":"De Rose F, Carmen De Santis M, Lucidi S, Ray Colciago R, Marino L, Cucciarelli F et al (2025) Dose constraints in breast cancer radiotherapy. A critical review. Radiother Oncol 202:110591","journal-title":"Radiother Oncol"},{"issue":"5","key":"6520_CR37","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/01.sla.0000254418.90192.59","volume":"245","author":"WC Jennings","year":"2007","unstructured":"Jennings WC, Baker RS, Murray SS, Howard CA, Parker DE, Peabody LF et al (2007) Primary breast lymphoma: the role of mastectomy and the importance of lymph node status. Ann Surg 245(5):784\u2013789","journal-title":"Ann Surg"},{"issue":"6","key":"6520_CR38","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s12282-022-01382-w","volume":"29","author":"MK Mustafa Ali","year":"2022","unstructured":"Mustafa Ali MK, Samhouri Y, Law JY, Khan C, Wegner R, Lee ST et al (2022) Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis. Breast Cancer 29(6):1022\u20131031","journal-title":"Breast Cancer"},{"issue":"1","key":"6520_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","volume":"92","author":"J Yahalom","year":"2015","unstructured":"Yahalom J, Illidge T, Specht L, Hoppe RT, Li YX, Tsang R et al (2015) Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 92(1):11\u201331","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06520-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06520-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06520-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T02:30:45Z","timestamp":1764729045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06520-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["6520"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06520-w","relation":{},"ISSN":["1432-0584"],"issn-type":[{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require approval from the institutional review board due to the de-identified information in the SEER program.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}